- Science & Research
- Science News
- Newsletter
- 2004
- June 10
Newsletter
Newsletter
Vitamin C may offer protection against rheumatoid arthritis
June 10, 2004 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
Life Extension Update Exclusive Vitamin C may offer protection against rheumatoid arthritis British researchers analyzed data obtained from the Norfolk, England arm of the European Prospective Investigation of Cancer (EPIC), which enrolled men and women aged 45 to 74 between1993 and 1997. Dietary information was provided by the completion of seven day diet diaries by 23,654 participants at the beginning of the study. Seventy-three participants developed inflammatory polyarthritis, a condition in which there is inflammation in two or more joints and which frequently meets or goes on to meet the criteria for rheumatoid arthritis. These patients were each age and sexed matched with two controls that did not have the condition. It was discovered that a low intake of fruits and vegetables was associated with twice the risk of developing inflammatory polyarthritis compared to those who reported a high intake. Vitamin C intake appeared to be even more important, with individuals whose consumption of the vitamin was in the lowest one third (less than 55.7 milligrams) having three times the risk of those whose vitamin C was in the highest third. When individuals whose vitamin C intake was below the UK recommended daily intake of 40 milligrams per day were compared to those whose intake was above this level, they were found to have an increased risk of inflammatory polyarthritis that was almost four times greater. Beta-carotene and vitamin E also appeared to have preventive properties, however they were not as protective as vitamin C. These results may have implications for the prevention of inflammatory polyarthritis and rheumatoid arthritis. | ||||||||||||||||||||||||||||||
Protocol Arthritis Inflammation is a living tissue response to mechanical, chemical, and immunological challenge. Normal aging often results in the excessive production of autoimmune factors that destroy joint cartilage and other tissues in the body. Suppressing these inflammatory factors is a critical component of an effective arthritis treatment program. Inflammation is partially characterized by high levels of arachidonic acid products which are metabolized along two different enzymatic pathways: cyclooxygenase (COX) and lipoxygenase, leading to prostaglandin (PGE-2) and leukotriene (LTB4). Some physicians believe these are the most important mediators of inflammation (Srivastava et al. 1992). PGE2 and LTB4 play a crucial role in arthritis by causing resorption of bone, stimulating the secretion of collagen breakdown enzymes, and inhibiting the formation of proteoglycans--the building blocks of cartilage. The destruction of cartilage and bone in both osteoarthritis (OA) and rheumatoid arthritis (RA) is related to the action of matrix enzymes (metalloproteinases), which include collagenases and stromelysins (Birkedal-Hansen et al. 1993; Hill et al. 1994). Some of these enzymes have proinflammatory characteristics and some have anti-inflammatory properties. The varying balance between these forces probably accounts for the variation in disease activity as it flares up and subsides. These enzymes are under the control of cytokines, such as interleuken 1 (IL-1b) and tumor necrosis factor-alpha (TNF-alpha), which are highly activated in RA and are elevated in the synovial membrane, the synovial fluid, and the cartilage of OA patients (Saklatvala 1986). Cytokines are proteins that carry messages between cells and regulate immunity and inflammation. In animal models, inhibition of TNF-alpha results in decreased inflammation, while inhibition of IL-1b effectively prevents cartilage destruction (Plows et al. 1995; Frye et al. 1996). As noted, TNF-alpha and IL-1b have been identified as factors in the destruction of cartilage in both OA and RA. Studies show that the blockade of these aberrant immune factors can produce therapeutic results. Nettle leaf has been shown to reduce TNF-alpha levels and IL-1b. Nettle leaf also inhibits the genetic transcription factor that activates TNF-alpha in synovial tissue. https://www.lifeextension.com/protocols/immune-connective-joint/osteoarthritis | ||||||||||||||||||||||||||||||
ArthroPro System The ArthroPro multi-nutrient formula:
https://www.lifeextension.com/newshop/items/item00620.html Fat-soluble vitamin C (ascorbyl palmitate) may be as important as water-soluble vitamin C, yet most vitamin consumers have not even heard of ascorbyl palmitate. If you take Life Extension Mix, you are receiving a potent dose of fat-soluble ascorbyl palmitate. Each capsule of Dual-C contains 677 mg of fully reacted calcium ascorbate (gentle on the stomach and supplies calcium) and ascorbyl palmitate (to protect fat tissues from oxidation). | ||||||||||||||||||||||||||||||
If you have questions or comments concerning this issue or past issues of Life Extension Update send them to ddye@lifeextension.com or call 954 766 8433 extension 7716. For longer life, Dayna Dye Sign up for Life Extension Update at https://mycart.lifeextension.com/subscribe.asp Help spread the good news about living longer and healthier. Forward this email to a friend! View previous issues of Life Extension Update in the Newsletter Archive. |
Lab
Testing
How Life Extension lab testing works